Literature DB >> 23215749

Atrial trans-septal thrombus in massive pulmonary embolism salvaged by prolonged extracorporeal life support after thrombo-embolectomy. A bridge to right-sided cardiovascular adaptation.

Thijs S R Delnoij, Ryan E Accord, Patrick W Weerwind, Dirk W Donker.   

Abstract

Massive pulmonary embolism poses a therapeutic challenge, especially when thrombolytics are controversial. We describe the complicated course of an exceptional case of massive pulmonary embolism exhibiting paradoxic embolization with a thrombus lodged in the foramen ovale. Thrombolysis was considered contraindicated and surgical intervention was performed. Postoperatively, persistent pulmonary hypertension and impending right ventricular (RV) failure necessitated the initiation of extracorporeal life support (ELS), accompanied by therapeutic heparinization, inhaled nitric oxide, levosimendan and sildenafil. On day 8, the patient was successfully weaned from ELS with excellent neurological recovery and virtual normalization of RV pressures and dimensions. (Contra-) indications for thrombolysis and surgical embolectomy are reviewed. The intriguing role of ELS in conjunction with therapeutic heparinization and pharmacological unloading of the right-sided vasculature and the RV is discussed.

Entities:  

Mesh:

Year:  2012        PMID: 23215749     DOI: 10.3109/17482941.2012.741247

Source DB:  PubMed          Journal:  Acute Card Care        ISSN: 1748-2941


  3 in total

1.  In-Hospital Outcome in Patients Underwent Extracorporeal Membrane Oxygenation in Life-Threatening High-Risk Pulmonary Embolism.

Authors:  Jung Hyun Choi; Sang Yeub Lee; Yong Hyun Park; Jae-Hyeong Park; Kye Hun Kim
Journal:  Int J Heart Fail       Date:  2020-05-27

Review 2.  Extracorporeal life support in cardiogenic shock: indications and management in current practice.

Authors:  C L Meuwese; F Z Ramjankhan; S A Braithwaite; N de Jonge; M de Jong; M P Buijsrogge; J G D Janssen; C Klöpping; J H Kirkels; D W Donker
Journal:  Neth Heart J       Date:  2018-02       Impact factor: 2.380

3.  Percutaneous mechanical thrombectomy in patients with high-risk pulmonary embolism and contraindications for thrombolytic therapy.

Authors:  Matjaz Bunc; Klemen Steblovnik; Simona Zorman; Peter Popovic
Journal:  Radiol Oncol       Date:  2020-02-14       Impact factor: 2.991

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.